Concomitant difluoromethylornithine/ sulindac chemoprevention of colorectal adenomas: a major clinical advance
Combining two drugs, i.e. difluoromethylornithine and sulindac, at low doses has been shown, for the first time, to provide both great efficacy and great safety for clinical colon cancer prevention. Download full article